DrugPatentWatch Database Preview
Profile for Russian Federation Patent: 2535347
US Patent Family Members and Approved Drugs for Russian Federation Patent: 2535347
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Jun 27, 2031 | Abbvie Inc | VENCLEXTA | venetoclax |
➤ Sign Up | May 26, 2030 | Abbvie Inc | VENCLEXTA | venetoclax |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |